Biochemical markers play a fundamental role in the diagnostic work-up and prognostic assessment of patients with cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Supports biomarker use in cardiomyopathy evaluation; leaves open validation of emerging markers in prospective studies.
Coats et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: